Financial News
(OP: NUMIF )
0.0237
+0.0015
(+6.76%)
Streaming Delayed Price
Updated: 2:46 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about NUMIF
Psychedelic Stock Gainers And Losers From November 30, 2022
November 30, 2022
Via Benzinga
![](https://pressreach.com/wp-content/uploads/2022/11/Depositphotos_464272662_xl-2015-1024x548.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/29/pawel-czerwinski-sljuhpqec0k-unsplash.jpg?width=1200&height=800&fit=crop)
Numinus Wellness Inc.'s Q4 And Fiscal 2022 Report Shows Revenues Grew 464% To $4.2M
November 29, 2022
Via Benzinga
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_205.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Psychedelic Stock Gainers And Losers From November 25, 2022
November 25, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From November 24, 2022
November 24, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_202.png?width=1200&height=800&fit=crop)
Psychedelic Stock Gainers And Losers From November 23, 2022
November 23, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
November 22, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/22/ketamine_clinic_mart_production_by_pexels_and_ju_by_wikimedia_commons.jpg?width=1200&height=800&fit=crop)
Psychedelic Stock Gainers And Losers From November 21, 2022
November 21, 2022
Via Benzinga
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
November 18, 2022
Via Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 17, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
November 16, 2022
Via Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
November 15, 2022
Via Benzinga
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Via Talk Markets
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_193.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_192.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_191.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_190.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_188.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_187.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/01/jonathan-velasquez-c1zn57gfdb0-unsplash.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/28/ketamine_clinic_rodnae_productions_by_pexels_and_doc_james_by_wikimedia_commons.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/28/felipepelaquim-wtghdgrkgwo-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://pressreach.com/wp-content/uploads/2022/10/Numinus-Wellness-Inc.-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_183.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_182.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.